Alzheimer Disease Treatment With Acetylcholinesterase Inhibitors and Incident Age-Related Macular Degeneration.
Saved in:
| Title: | Alzheimer Disease Treatment With Acetylcholinesterase Inhibitors and Incident Age-Related Macular Degeneration. |
|---|---|
| Authors: | Sutton SS; Dorn Research Institute, Columbia VA Health Care System, Columbia, South Carolina.; Department of Clinical Pharmacy and Outcomes Sciences, College of Pharmacy, University of South Carolina, Columbia., Magagnoli J; Dorn Research Institute, Columbia VA Health Care System, Columbia, South Carolina.; Department of Clinical Pharmacy and Outcomes Sciences, College of Pharmacy, University of South Carolina, Columbia., Cummings TH; Dorn Research Institute, Columbia VA Health Care System, Columbia, South Carolina.; Department of Clinical Pharmacy and Outcomes Sciences, College of Pharmacy, University of South Carolina, Columbia., Hardin JW; Dorn Research Institute, Columbia VA Health Care System, Columbia, South Carolina.; Department of Epidemiology & Biostatistics, University of South Carolina, Columbia., Ambati J; Center for Advanced Vision Science, University of Virginia School of Medicine, Charlottesville.; Department of Ophthalmology, University of Virginia School of Medicine, Charlottesville.; Department of Pathology, University of Virginia School of Medicine, Charlottesville.; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville. |
| Source: | JAMA ophthalmology [JAMA Ophthalmol] 2024 Feb 01; Vol. 142 (2), pp. 108-114. |
| Publication Type: | Observational Study; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589539 Publication Model: Print Cited Medium: Internet ISSN: 2168-6173 (Electronic) Linking ISSN: 21686165 NLM ISO Abbreviation: JAMA Ophthalmol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
